Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIES from Wavre, company number BE0452520638, closed financial year 2025 with a result of € 0 after tax. Compared with financial year 2024, the result moved from € 0 to € 0. Around break-even. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ -18,296
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -36,896.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | - | € 345 | - | - | |
| Profit after taxes | € -80 | € -40 | € 0 | € 0 | |
| Equity | € -18,256 | € -18,296 | € -18,296 | € -18,296 | |
| Total debts | € 18,289 | € 18,296 | € 18,296 | € 18,296 | |
| Cash | € 33 | - | - | - | |
| Retained profit | € -36,856 | € -36,896 | € -36,896 | € -36,896 | |
| Balance sheet total | € 33 | € 0 | € 0 | € 0 |
Key figures of BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIES?
What happened at BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. filed late Source: NBB ↗
- New establishment in Rixensart. KBO
- Start of the company according to the CBE. KBO
In short
From € 80 loss in 2022 to € 0 profit in 2025.
A new publication or filing at BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIES? We notify you, reason included.
Follow BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIES is Kalenga Ilunga.
Directors
According to the 2025 annual accounts
Kalenga Ilunga
Manager
Establishments
Establishment units
Physical locations of this company
Avenue René Magritte 9
1300 Wavre
Avenue Beau Rivage 19
1332 Rixensart
Active since 14 February 1996
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →ORAMED
€ 14,706 gross margin · 2025
AM INVESTOR SERVICES
€ 4,287 gross margin · 2024
FONDATION GALUNI POUR LE DEVELOPPEMENT AFRICAIN
Galuni Investment Partners IC
GALUNI INVESTMENT PARTNERS
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0452.520.638
- VAT number
- BE 0452.520.638
- Registered office
- Avenue René Magritte 9, 1300 Wavre
- Names & denominations
- BUREAU D'EVALUATION DES SOINS DE SANTE ET DES TECHNOLOGIES · BEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 April 1994
- Peppol
- Not registered